Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB/c mouse model

The vesicular stomatitis virus variant VSV-GP is an oncolytic virus (OV) platform extensively studied in preclinical settings, which recently entered clinical trial testing. For oncolytic virotherapy, innate and adaptive immune system activation are considered major contributors. However, upon OV tr...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sarah Danklmaier, Saskia V. Vijver, Lisa Pipperger, Gabriel Floriani, Lukas Perro, Vanessa Konrad, Tamara Hofer, Hubert Hackl, Krishna Das, Guido Wollmann
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-12-01
סדרה:	Molecular Therapy: Oncology
נושאים:	MT: Regular Issue VSV CD8+ T cell epitope prediction oncolytic virus anti-viral immunity
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2950329925001419
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!